Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus

被引:40
作者
Wilda, M
Busch, K
Klose, I
Keller, T
Woessmann, W
Kreuder, J
Harbott, J
Borkhardt, A
机构
[1] LMU Munich, D-80337 Munich, Germany
[2] Childrens Univ Hosp, Dept Pediat Hematol & Oncol, Giessen, Germany
[3] ACOMED Stat, Leipzig, Germany
[4] Childrens Univ Hosp, Dept Pediat Cardiol, Giessen, Germany
关键词
D O I
10.1002/gcc.20063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increased transcriptional activity of the MYC gene is a characteristic feature of Burkitt's lymphoma. Aberrant MYC expression is caused by (1) chromosomal translocation to one of the loci carrying an immunoglobulin gene, (2) mutation within the translocated allele, (3) loss of the block to transcription elongation, or (4) promoter shift. To investigate the influence of breakpoint locations within the MYC gene on MYC transcript levels, we determined both the precise genomic MYC/IGH breakpoints and the amount of MYC mRNA in 25 samples of pediatric Burkitt's lymphoma with translocation t(8;14)(q24;q32). Patients with breakpoints that were 5' from MYC exon 1 had significantly lower expression of MYC than did patients who had a breakpoint within exon 1 or intron 1 (P < 0.05 and 0.005, respectively). The highest mRNA level of MYC (1,006 copies per 100 copies ABL1) was detected in patients with loss of the first exon and transcription initiation from a cryptic P3 promoter within the first intron of the MYC gene. In contrast, there was no obvious correlation between breakpoint locations within the IgH locus and the amount of MYC mRNA. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 14 条
[1]   MUTATIONS IN THE 1ST EXON ARE ASSOCIATED WITH ALTERED TRANSCRIPTION OF C-MYC IN BURKITT-LYMPHOMA [J].
CESARMAN, E ;
DALLAFAVERA, R ;
BENTLEY, D ;
GROUDINE, M .
SCIENCE, 1987, 238 (4831) :1272-1275
[2]   HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J].
DALLAFAVERA, R ;
BREGNI, M ;
ERIKSON, J ;
PATTERSON, D ;
GALLO, RC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7824-7827
[3]   REGULATORY ELEMENTS THAT MODULATE EXPRESSION OF HUMAN C-MYC [J].
HAY, N ;
BISHOP, JM ;
LEVENS, D .
GENES & DEVELOPMENT, 1987, 1 (07) :659-671
[4]   Molecular biology of Burkitt's lymphoma [J].
Hecht, JL ;
Aster, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :3707-3721
[5]   CHARACTERIZATION OF THE HUMAN-IMMUNOGLOBULIN KAPPA GENE 3 ENHANCER - FUNCTIONAL IMPORTANCE OF 3 MOTIFS THAT DEMONSTRATE B-CELL-SPECIFIC INVIVO FOOTPRINTS [J].
JUDDE, JG ;
MAX, EE .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (11) :5206-5216
[6]   IDENTIFICATION OF A LOCUS-CONTROL REGION IN THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS THAT DEREGULATES C-MYC EXPRESSION IN PLASMACYTOMA AND BURKITTS-LYMPHOMA CELLS [J].
MADISEN, L ;
GROUDINE, M .
GENES & DEVELOPMENT, 1994, 8 (18) :2212-2226
[7]  
Palomo C, 1999, CANCER RES, V59, P5625
[8]  
SNYDER R C, 1992, Critical Reviews in Oncogenesis, V3, P283
[9]   THE BLOCK TO TRANSCRIPTION ELONGATION IS PROMOTER DEPENDENT IN NORMAL AND BURKITTS-LYMPHOMA C-MYC ALLELES [J].
SPENCER, CA ;
LESTRANGE, RC ;
NOVAK, U ;
HAYWARD, WS ;
GROUDINE, M .
GENES & DEVELOPMENT, 1990, 4 (01) :75-88
[10]   ACTIVATION AND SOMATIC MUTATION OF THE TRANSLOCATED C-MYC GENE IN BURKITT-LYMPHOMA CELLS [J].
TAUB, R ;
MOULDING, C ;
BATTEY, J ;
MURPHY, W ;
VASICEK, T ;
LENOIR, GM ;
LEDER, P .
CELL, 1984, 36 (02) :339-348